Umezawa, Natsuka
Kawahata, Kimito
Mizoguchi, Fumitaka
Kimura, Naoki
Yoshihashi-Nakazato, Yoko
Miyasaka, Nobuyuki
Kohsaka, Hitoshi
Article History
Received: 4 November 2017
Accepted: 5 March 2018
First Online: 3 April 2018
Competing Interests
: H.K. has received consulting fees and/or speaking fees from Abbott Japan, AbbVie, Astellas Pharma, Eli Lilly and Company, Glaxo Smith Kline, Janssen Pharmaceutical, Japan Blood Products Organization, Mitsubishi Tanabe Pharma, Novartis Pharma Japan and UCB Japan. N.U., K.K., F.M., N.K., Y.Y.-N. and N.M. declare no potential conflict of interest.